Safety and Immunogenicity Study of Tdap Vaccinations for Plasma Donors
Phase 2
Active, not recruiting
- Conditions
- Tetanus, Diphtheria and Acellular Pertussis Vaccination
- Interventions
- Biological: Tdap
- First Posted Date
- 2022-12-23
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- ABO Holdings, Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT05662852
- Locations
- 🇺🇸
ABO Plasma, Glassboro, New Jersey, United States
© Copyright 2025. All Rights Reserved by MedPath